Alterations in Memory Networks in Mild Cognitive Impairment and Alzheimer's Disease: An Independent Component AnalysisKim Celone, Reisa A. Sperling, Vince D. Calhoun et al.|Journal of Neuroscience|2006Cited by 760
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trialRandall J. Bateman, Bruno Dubois, David B. Clifford et al.|The Lancet Neurology|2025Cited by 39